Akari Therapeutics
$1.769876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$1.76
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
-$0.05 (-2.81%) Today
+$0.03 (1.73%) As of 7:29 PM EDT after-hours
Why Robinhood?
You can buy or sell AKTX and other stocks, options, ETFs, and crypto commission-free!
About AKTX
Akari Therapeutics Plc ADR, also called Akari Therapeutics, is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of therapeutics to treat orphan autoimmune and inflammatory diseases. Its lead product candidate, Nomacopan, is a second-generation complement inhibitor. Read More The company was founded on October 7, 2004 and is headquartered in London, the United Kingdom.
Employees
14
Headquarters
London, London & South East
Founded
2004
Market Cap
32.44M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
4.15M
High Today
$1.83
Low Today
$1.68
Open Price
$1.77
Volume
390.81K
52 Week High
$9.20
52 Week Low
$1.56
Collections
AKTX News
Price Paid on Robinhood
66% Lower
Right Now
52 Week Low
$1.56
Average Price Paid
$5.12
52 Week High
$9.20
AKTX Earnings
-$0.66
-$0.44
-$0.22
$0.00
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Estimated
—
Actual
Expected Sep 26, Pre-Market